|
Platelet function inhibitors
Citations 81-90 of 251 total displayed.
|
Past content
(since Oct 2000):
|
- Articles
Absorption, Metabolization, and Antiplatelet Effects of 300-, 600-, and 900-mg Loading Doses of Clopidogrel. Results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial
- Nicolas von Beckerath, Dirk Taubert, Gisela Pogatsa-Murray, Edgar Schömig, Adnan Kastrati, and Albert Schömig
Circulation published October 31, 2005, doi:10.1161/CIRCULATIONAHA.105.559088
[Abstract]
- Correspondence
Letters Regarding Article by Patti et al, "Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention: Results From the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) Study" • Response
- Pierluigi Tricoci, Robert A. Harrington, Marco Valgimigli, Theresa M. Palabrica, Paul B. Burton, Giuseppe Patti, Leonardo Lassandro Pepe, Germano Di Sciascio, Giuseppe Colonna, Antonio Montinaro, and Vincenzo Pasceri
Circulation 2005;112:e282-283e, doi:10.1161/CIRCULATIONAHA.105.568139
[Full text]
- Basic Science for Clinicians
Molecular Regulation of Platelet-Dependent Thrombosis
- Jane E. Freedman
Circulation 2005;112:2725-2734, doi:10.1161/CIRCULATIONAHA.104.494468
[Abstract]
[Full text]
- Correspondence
Letter Regarding Article by Luo et al, "Adenovirus-Mediated Expression of ß-Adrenergic Receptor Kinase C-Terminus Reduces Intimal Hyperplasia and Luminal Stenosis of Arteriovenous Polytetrafluoroethylene Grafts in Pigs" • Response
- Joris I. Rotmans, Erik S.G. Stroes, Gerard Pasterkamp, Zhengyu Luo, Geoffrey Y. Akita, Taro Date, Christopher Treleaven, Karen A. Vincent, Denise Woodcock, Seng H. Cheng, Richard J. Gregory, and Canwen Jiang
Circulation 2005;112:e153, doi:10.1161/CIRCULATIONAHA.105.559930
[Full text]
- Surgery for Coronary Artery Disease
Aprotinin Decreases Postoperative Bleeding and Number of Transfusions in Patients on Clopidogrel Undergoing Coronary Artery Bypass Graft Surgery: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial
- Jan van der Linden, Gabriella Lindvall, and Ulrik Sartipy
Circulation 2005;112:I-276-280I-, doi:10.1161/CIRCULATIONAHA.104.524611
[Abstract]
[Full text]
- Surgery for Coronary Artery Disease
Preoperative Aspirin Therapy Is Associated With Improved Postoperative Outcomes in Patients Undergoing Coronary Artery Bypass Grafting
- Kevin A. Bybee, Brian D. Powell, Uma Valeti, A. Gabriela Rosales, Stephen L. Kopecky, Charles Mullany, and R. Scott Wright
Circulation 2005;112:I-286-292I-, doi:10.1161/CIRCULATIONAHA.104.522805
[Abstract]
[Full text]
- Controversies in Cardiovascular Medicine
Periprocedural Cardiac Enzyme Elevation Predicts Adverse Outcomes
- Deepak L. Bhatt and Eric J. Topol
Circulation 2005;112:906-922, doi:10.1161/CIRCULATIONAHA.104.483297
[Full text]
- Coronary Heart Disease
Randomized Comparison of Prasugrel (CS-747, LY640315), a Novel Thienopyridine P2Y12 Antagonist, With Clopidogrel in Percutaneous Coronary Intervention: Results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)–TIMI 26 Trial
- Stephen D. Wiviott, Elliott M. Antman, Kenneth J. Winters, Govinda Weerakkody, Sabina A. Murphy, Bruce D. Behounek, Robert J. Carney, Charles Lazzam, Raymond G. McKay, Carolyn H. McCabe, Eugene Braunwald for the JUMBO–TIMI 26 Investigators
Circulation 2005;111:3366-3373; published online before print as doi:10.1161/CIRCULATIONAHA.104.502815
[Abstract]
[Full text]
- Articles
Randomized Comparison of Prasugrel (CS-747, LY640315), a Novel Thienopyridine P2Y12 Antagonist, With Clopidogrel in Percutaneous Coronary Intervention. Results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 Trial
- Stephen D. Wiviott, Elliott M. Antman, Kenneth J. Winters, Govinda Weerakkody, Sabina A. Murphy, Bruce D. Behounek, Robert J. Carney, Charles Lazzam, Raymond G. McKay, Carolyn H. McCabe, Eugene Braunwald for the JUMBO-TIMI 26 Investigators
Circulation published June 20, 2005, doi:10.1161/CIRCULATIONAHA.104.502815
[Abstract]
- Correspondence
Letters Regarding Article by Mehilli et al, "Randomized Clinical Trial of Abciximab in Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions After Treatment With a High Loading Dose of Clopidogrel" • Response
- Áurea J. Chaves, Amanda G.M.R. Sousa, John W. Eikelboom, James M. Rankin, Adnan Kastrati, Julinda Mehilli, Helmut Schühlen, Alban Dibra, Jürgen Pache, Albert Schömig, Nicolas von Beckerath, Hildegard Bollwein, Josef Dirschinger, Franz Dotzer, and Peter P. Berger
Circulation 2005;111:e370-371e, doi:10.1161/CIRCULATIONAHA.104.529735
[Full text]
|
|
